12/1 Business Wire Health: Alternative Medicine News

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. Business Wire Health: Alternative Medicine News PanGenex Signs Licensing Deal to the Enter the $600 Million Spirulla Market November 30, 2009 at 4:39 pm CLEARWATER, Fla.--(BUSINESS WIRE)--PanGenex Corporation (Pink Sheets:PGCX), a global nutraceutical and dietary supplement manufacturer and marketer, announced today that it has solidified plans to expand its retail product line with the addition of spirulla. Spirulla, a blue green algae, is an abundant and sustainable natural source of protein, essential fatty acids, vitamins, B12 and minerals that has been used as a dietary health supplement for centuries. Through a licensing agreement with Gre Introducing anuleaf AD, a Revolutionary New Hemorrhoid Treatment November 30, 2009 at 12:41 pm NEW YORK--(BUSINESS WIRE)--Many drug companies desperately do not want revealed to the public that over-the-counter hemorrhoid treatments may worsen problems and cause skin damage. "Steroid creams in particular may cause permanent damage or ulceration of perianal skin," states Laurie Barclay, MD, and Charles Vega, MD in their medical study published in the February 16, 2008 issue of BMJ. Brand-name hemorrhoid treatments have touted the relief effects of their products for years, but they ha Cannabis Science Appoints Three Distinguished Physicians As New Members To Its Scientific Advisory Board: Dr. Ben Johnson, Dr. Alan Shackleford, and Dr. William Courtney November 30, 2009 at 9:09 am COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is honored to announce that Dr. Ben Johnson, Dr. Allan Shackleford and Dr. William Courtney have accepted its request to become members of its recently formed Scientific Advisory Board. The formation of the Scientific Advisory Board was announced on August 6th with the appointment of Dr. Mitch Earlywine Ph. D. as its first member, and the appointment Dr. Ritchard L. Fis   This email was sent to billionlys.asdf1234@blogger.com.  Manage Your Account Don't want to receive this feed any longer? Unsubscribe here.

12/1 Business Wire Health: Medical Supplies News

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. Business Wire Health: Medical Supplies News Idaho Technology's FilmArray™ Receives Military Funding for CLIA Waiver Effort November 30, 2009 at 5:17 pm SALT LAKE CITY--(BUSINESS WIRE)--The Defense Threat Agency (DTRA), on behalf of the U.S. Air Force Assistant Surgeon General, Modernization Directorate (AF/SGR), has awarded Idaho Technology, Inc. $3.3 million to advance development of the FilmArray™ system and pursue Clinical Laboratory Improvement Amendments (CLIA) waiver from the Food and Drug Administration (FDA). CLIA waiver applies to tests that are simple to perform and interpret, such as rapid Strep tests and pregnancy tests, and c Media Files ViewMedia?mgid=177922&vid=2 (2 KB) PanGenex Signs Licensing Deal to the Enter the $600 Million Spirulla Market November 30, 2009 at 4:39 pm CLEARWATER, Fla.--(BUSINESS WIRE)--PanGenex Corporation (Pink Sheets:PGCX), a global nutraceutical and dietary supplement manufacturer and marketer, announced today that it has solidified plans to expand its retail product line with the addition of spirulla. Spirulla, a blue green algae, is an abundant and sustainable natural source of protein, essential fatty acids, vitamins, B12 and minerals that has been used as a dietary health supplement for centuries. Through a licensing agreement with Gre Stericycle, Inc. Receives Clearance to Acquire MedServe, Inc. November 30, 2009 at 2:51 pm LAKE FOREST, Ill.--(BUSINESS WIRE)--Stericycle, Inc. (NASDAQ:SRCL), today announced that it has entered into an agreement with the United States Department of Justice and the States of Missouri and Nebraska providing clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 that will allow Stericycle to complete its pending acquisition of MedServe, Inc. Stericycle expects to complete this acquisition during the fourth quarter of 2009, as previously announced. The agreement require Media Files ViewMedia?mgid=181177&vid=2 (2 KB) Introducing anuleaf AD, a Revolutionary New Hemorrhoid Treatment November 30, 2009 at 12:41 pm NEW YORK--(BUSINESS WIRE)--Many drug companies desperately do not want revealed to the public that over-the-counter hemorrhoid treatments may worsen problems and cause skin damage. "Steroid creams in particular may cause permanent damage or ulceration of perianal skin," states Laurie Barclay, MD, and Charles Vega, MD in their medical study published in the February 16, 2008 issue of BMJ. Brand-name hemorrhoid treatments have touted the relief effects of their products for years, but they ha Hospitals, Healthcare Providers to Save with Premier's New High Level Disinfection Reprocessing Agreements November 30, 2009 at 9:00 am CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier Purchasing Partners, LP, today announced new agreements for high level disinfection reprocessing have been awarded to Hygia Health Services of Birmingham, Ala., a small business and woman owned business enterprise; and ReNu Medical Inc. of Everett, Wash., a small business and veteran owned business enterprise. Effective January 1, 2010, the agreements are available to acute care and continuum of care members of the Premier healthcare alliance. About Media Files ViewMedia?mgid=38202&vid=2 (2 KB) GE Healthcare Announces Multi-Center Study To Investigate Performance Of MBIR For Ultra-Low Dose CT Exams November 30, 2009 at 8:30 am CHICAGO--(BUSINESS WIRE)--GE Healthcare, a $17 billion unit of General Electric Company (NYSE:GE), announced today a multi-center study to investigate the performance of Model Based Iterative Reconstruction (MBIR) as a method to maintain or improve diagnostic information available to clinicians while dramatically lowering radiation dose in routine CT imaging. Over the past several years, CT has continued to demonstrate value due to its versatile diagnostic capability, non-invasive application an Covidien Completes Sale of Oxygen Therapy Product Line November 30, 2009 at 7:00 am DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it had completed the previously announced sale of its Oxygen Therapy assets to Chart Industries, Inc. (NASDAQ: GTLS). Financial terms of the transaction were not disclosed. The sale of the Oxygen Therapy product line, which includes products sold under the Companion™ and Helios™ brands, was made following a thorough review and evaluation of a number of strategic alter Media Files ViewMedia?mgid=178058&vid=2 (2 KB) UnitedHealth Group to Host Investor Conference November 30, 2009 at 7:00 am MINNEAPOLIS--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) will host its annual Investor Conference with institutional analysts and investors in New York City on Tuesday, December 1, 2009 beginning at 8:00 a.m. EST. The meeting will include presentations from a variety of senior leaders who will discuss the Company’s performance and outlook, including reviewing business trends and specific initiatives related to its various business units. The Company will also host an audio webcast of t Media Files ViewMedia?mgid=189579&vid=2 (2 KB)   This email was sent to billionlys.asdf1234@blogger.com.  Manage Your Account Don't want to receive this feed any longer? Unsubscribe here.